Imaging & Diagnosis Center
PatientCenter
VascularTherapy.OrgBlogDiscussion Forum
Home » Imaging News » April 3, 2007

Johns Hopkins University Installs
Toshiba Infinix DP-i/FD2

New Vascular Imaging System Increases Patient Comfort and Decreases Exam Time


April 3, 2007 -- TUSTIN, Calif. -- The Johns Hopkins University School of Medicine and its Heart Institute is installing the Infinix™ DP-i/FD2 imaging system from Toshiba America Medical Systems, Inc. Johns Hopkins will use the system for detailed peripheral vascular work and coronary studies for more efficient, comprehensive patient care.

The advantage of the Infinix Dual Plane system is having two independent flat panel detectors in the same room, one flat panel detector for coronary imaging and the other flat panel detector for vascular studies. This increases patient comfort and decreases exam time by eliminating the need to move the patient. products, visit www.medical.toshiba.com.

"Johns Hopkins is a leading health institution with a reputation for excellence, and Toshiba is honored to partner with them to help round out the capabilities of their already-impressive cardiology offerings," said Robert Micer, director, X-Ray Vascular Business Unit, Toshiba. "The Infinix DP-i/FD2 is an ideal system to meet the facility's cardiac and vascular imaging demands without compromise, and enables Johns Hopkins to obtain high-quality images with accurate anatomical detail, which results in improved diagnosis and treatment recommendations for their patients." products, visit www.medical.toshiba.com.

About the Infinix DP-i/FD2 system
The Infinix offers a parallel processing system architecture, which permits background image processing and archiving without interrupting the exam. This powerful process enhances department work-flow and patient throughput. products, visit www.medical.toshiba.com.

The system is equipped with tableside dose management and provides a unique twenty frames per second fluoroscopy setting, reducing the patient dose routinely by 25 percent without compromising image quality. Additionally, the Windows®-based operating system provides an intuitive user interface familiar to most operators. Both the triple focus liquid-metal bearing tube for peripheral exams and the dual-focus tube for cardiac exams have a 3.0 million anode heat capacity. This industry-leading rating eliminates delays and increases throughput. products, visit www.medical.toshiba.com.

For more information about the Infinix DP-i/FD2 system, Toshiba or its wide range of medical imaging products, visit www.medical.toshiba.com.

About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 172,000 employees worldwide and annual sales of $54 billion.

Source: Toshiba America Medical Systems

(Disclaimer: external links to news, press releases and other timely information sources are provided as a service by Angioplasty.Org, which is not responsible for the content found on any external sites. Items marked with a ($$) indicate that the external site normally restricts viewing to paid subscribers. Other sites may require free registration.

Angioplasty.Org Home •  PatientCenter


send comments & suggestions to "info at angioplasty dot org"
read Terms of Use and Privacy statement

Angioplasty.Org is an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
Unless otherwise noted, all content, including text, photos and video
© Copyright Venture Digital LLC 1996-2021